Peak6 Investments LLC Bei Gene, Ltd. Put Options Transaction History

Peak6 Investments LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $302,775 - $540,125	-2,500 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $366,300 - $673,900	2,500 New	2,500 $472,000
Q4 2019 Feb 13, 2020	SELL	$115.78 - $208.34 $463,120 - $833,360	-4,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$113.99 - $146.86 $148,187 - $190,918	-1,300 Reduced 24.53%	4,000 $496,000
Q1 2019 May 15, 2019	SELL	$122.82 - $151.83 $749,202 - $926,163	-6,100 Reduced 53.51%	5,300 $700,000
Q4 2018 Feb 13, 2019	BUY	$107.01 - $175.15 $749,070 - $1.23 Million	7,000 Added 159.09%	11,400 $1.6 Million
Q3 2018 Nov 13, 2018	BUY	$152.62 - $189.66 $671,528 - $834,504	4,400 New	4,400 $758,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.